LEXX Q1 2026 Earnings Narrower Loss Surprises as Bioscience Firm Advances Drug Delivery Pipeline VLYPO Q1 2026 Earnings Preferred EPS Beats Estimates as Bank Navigates Steady Earnings Environment Jade Biosciences Inc JBIO Q1 2026 Earnings EPS Miss Amid Continued PreRevenue Phase BSM Q1 2026 Earnings Significant EPS Miss Amid Weak Royalty Income JPM Q1 2026 Earnings Strong EPS Beat Despite Subdued Revenue Environment Nkarta Inc NKTX Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline